New nasal spray aims to shield asthmatics from common cold virus
NCT ID NCT07488897
Summary
This study is testing a new nasal spray called RIG-101 to see if it can help prevent asthma attacks triggered by the common cold virus. The trial has two parts: first checking the spray's safety in healthy people, then seeing if it reduces breathing problems in adults with asthma who are exposed to a cold virus. The goal is to control asthma symptoms better during respiratory infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AND EFFICACY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medicines Evaluation Unit
RECRUITINGManchester, M23 9QZ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virtus Respiratory Research Ltd
NOT_YET_RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.